BioSpace News Archive

Robotic Rehabilitation and Assistive Technologies Market: Overwhelming Demand for Rehabilitation Services Led to the Inception of Mobile Self-help Robots

Technological innovations in the robotic rehabilitation and assistive technologies landscape are offering people a second look at overcoming disability challenges.

August 25, 2020
·
5 min read
Subcutaneous Injection Ports Market: Increasing patient acceptance of these ports have boosted the generation of new opportunities in the market

Subcutaneous ports are a popular totally implantable device for a safe and fast delivery of multiple medications into a patient’s body.

August 25, 2020
·
5 min read
Viral Diagnostic Test Kits Market: Rise in incidence of viral infections to boost the market

Viral infections and pandemics have been exerting a significant economic cost burden on health care systems around the world.

August 25, 2020
·
5 min read
Substance Abuse Treatment Market: Alcohol addiction treatment segment to expand at significantly high growth rate

Substance abuse is the use of psychoactive substances, including alcohol and illicit drugs.

August 25, 2020
·
6 min read
Non Muscle Invasive and Metastatic Bladder Cancer (NMIBC) Market Drivers and Restraints Analysis to 2025

Non-muscle invasive and metastatic bladder cancer causes malignancy of the urinary tract.

August 25, 2020
·
4 min read
Biotech Beach

Hancock Jaffe Enrolls Initial Patients for First-in-Human CoreoGraft Study

Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that it has enrolled the first two patients for its first-in-human CoreoGraft study.

August 25, 2020
·
5 min read
Business

Biocom Institute, Illumina and Illumina Foundation Partner to Bring Genomics Education to the Classroom

Biocom Institute, a 501(c)(3) non-profit that supports life science innovation by strengthening the workforce and leaders of tomorrow, today announced a partnership with Illumina and the Illumina Foundation to advance the Illumina Genomic Discoveries Educator Program & Curriculum.

August 25, 2020
·
5 min read
FDA

U.S. FDA Approves CYSTADROPS® (Cysteamine Ophthalmic Solution) 0.37%, A New Practical Treatment Option for the Ocular Manifestations of Cystinosis

Recordati Rare Diseases Inc., today announced the U.S. Food and Drug Administration (FDA) has approved CYSTADROPS® (cysteamine ophthalmic solution) 0.37%. CYSTADROPS is a new, viscous eye drop solution that depletes corneal cystine crystal deposits in people living with cystinosis

August 25, 2020
·
6 min read
BioForest

Kubota Vision Completes POC Clinical Study Using Wearable Myopia Control Device Based on Kubota Glasses Technology

Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced the successful completion of a proof-of-concept (POC) clinical study using a wearable myopia control device based on Kubota Glasses technology.

August 25, 2020
·
6 min read
BioForest

Northwest Laboratory Announces Large-scale COVID-19 Testing Capacity with Rapid Resulting

In response to recent national backlogs of COVID-19 testing, Northwest Laboratory (NWL) has announced additional testing capacity to help alleviate shortages.

August 25, 2020
·
2 min read